Risedronate is a bisphosphonate used for: Treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis in men and glucocorticoid-induced osteoporosis. Paget’s disease of bone, to reduce bone turnover. It works by inhibiting bone resorption by osteoclasts. It is grouped under the following drug class(es): Bisphosphonates. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ridron and Benet. Its PubChem CID is 5245.
Risedronate
| CAS No | 105462-24-6 |
|---|---|
| Molecular Formula | C7H11NO7P2 |
| Molecular Weight | 283.11 g/mol |
| Synonyms | (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Risedronate is a bisphosphonate used for: Treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis in men and glucocorticoid-induced osteoporosis.
The listed CAS number is 105462-24-6.
The listed molecular formula is C7H11NO7P2.
The listed molecular weight is 283.11 g/mol.
(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid.
The source lists Ridron and Benet.